MAPK/ERK-CBP-RFPL-3 Mediates Adipose-Derived Stem Cell-Induced Tumor Growth in Breast Cancer Cells by Activating Telomerase Reverse Transcriptase Expression
暂无分享,去创建一个
C. Qian | Chunxiao Liu | W. Ma | Zhenlin Yang | Meng Liu | Jian Liu | Haiqian Xu | Xu Liu | Xiaojun Sun | Zhenghua Chen | Wenjie Li | Fei Ma
[1] H. Kreipe,et al. Transcription factor AP‐2beta in development, differentiation and tumorigenesis , 2021, International journal of cancer.
[2] C. Bai,et al. A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth , 2021, Journal of Cancer Research and Clinical Oncology.
[3] N. Zarghami,et al. Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways. , 2020, Biochimie.
[4] J. Nandakumar,et al. Molecular mechanisms of telomere biology disorders. , 2020, The Journal of biological chemistry.
[5] L. Sapio,et al. Targeting CREB in Cancer Therapy: A Key Candidate or One of Many? An Update , 2020, Cancers.
[6] Yu Jin,et al. Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways , 2020, Gastric Cancer.
[7] Yu Qin,et al. Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation , 2020, Cell Death & Disease.
[8] Young-sil Yoon,et al. Transcriptional co-activator regulates melanocyte differentiation and oncogenesis by integrating cAMP and MAPK/ERK pathways , 2020, bioRxiv.
[9] V. Tergaonkar,et al. Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential , 2020, Cancers.
[10] G. Peters,et al. Targeting telomerase for its advent in cancer therapeutics. , 2020, Medicinal research reviews.
[11] S. Park,et al. Development and characterization of a fully human antibody targeting SCF/c-kit signaling. , 2020, International journal of biological macromolecules.
[12] Ying Xu,et al. ERK/MAPK signalling pathway and tumorigenesis , 2020, Experimental and therapeutic medicine.
[13] Simone Brogi,et al. Telomerase-based cancer therapeutics: a review on their clinical trials. , 2020, Current topics in medicinal chemistry.
[14] Ping Chen,et al. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1) , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[15] Y. Cong,et al. Role of telomerase in the tumour microenvironment , 2019, Clinical and experimental pharmacology & physiology.
[16] Kangdong Liu,et al. Sulforaphene induces apoptosis and inhibits the invasion of esophageal cancer cells through MSK2/CREB/Bcl-2 and cadherin pathway in vivo and in vitro , 2019, Cancer Cell International.
[17] S. Luo,et al. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b. , 2019, Cellular signalling.
[18] C. Govind,et al. Mesenchymal stem cells: Cell therapy and regeneration potential , 2019, Journal of tissue engineering and regenerative medicine.
[19] P. Gentile,et al. Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities , 2019, International journal of molecular sciences.
[20] W. Jones,et al. CBP/p300 drives the differentiation of Regulatory T cells through transcriptional and non-transcriptional mechanisms. , 2019, Cancer research.
[21] A. Amadori,et al. A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer , 2019, Cell Death & Disease.
[22] A. Slusher,et al. Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer , 2019, Cancers.
[23] Ting Zhang,et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling , 2019, Cell Death & Disease.
[24] F. Jacobsen,et al. Influence of preadipocyte-conditioned medium on the proliferation and invasive potential of breast cancer cell lines in vitro , 2018, Archives of Gynecology and Obstetrics.
[25] Mohamed A. Nasr,et al. Telomerase reverse transcriptase coordinates with the epithelial-to-mesenchymal transition through a feedback loop to define properties of breast cancer stem cells , 2018, Biology Open.
[26] A. Perin,et al. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients , 2018, British Journal of Cancer.
[27] C. Qian,et al. c-Kit-Positive Adipose Tissue-Derived Mesenchymal Stem Cells Promote the Growth and Angiogenesis of Breast Cancer , 2017, BioMed research international.
[28] Wenlin Huang,et al. RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth , 2015, Oncotarget.
[29] G. Wei,et al. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells , 2014, Oncotarget.
[30] S. Agarwal,et al. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling. , 2013, Cellular signalling.
[31] K. Krause,et al. Primate-specific RFPL1 gene controls cell-cycle progression through cyclin B1/Cdc2 degradation , 2011, Cell Death and Differentiation.
[32] P. Khaitovich,et al. Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. , 2008, American journal of human genetics.
[33] A. Shukla,et al. Measuring agonist-induced ERK MAP kinase phosphorylation for G-protein-coupled receptors. , 2019, Methods in cell biology.